Distribution of human papillomavirus among women with abnormal cervical cytology in Kuwait
Affiliations
Affiliations
- Department of Medical Laboratory Sciences, Faculty of Allied Health Sciences, Kuwait University, Sulaibikhat 90805, Kuwait. r.al-awadhi@hsc.edu.kw
Abstract
This study investigates the distribution of human papillomavirus (HPV) in women with abnormal cervical cytology in Kuwait. Two hundred and ninety-eight (298) abnormal ThinPreps were taken from women seeking routine gynecological care and screened for HPV DNA by real-time PCR. HPV genotyping was determined by PCR-based sequencing. HPV DNA was detected in 152 women (51%), and 29 different HPV genotypes were detected, comprising 16 high-risk (HR) (16, 18, 31, 33, 35, 39, 45, 51, 53, 56, 58, 59, 66, 68, 73, 97), nine low-risk (LR) (6, 11, 54, 61, 74, 81, 90, 102, 106), and four intermediate-risk (IR) (62, 67, 84, 87). HPV16 had the highest prevalence (24.3%), followed by HPV11 (13.8%), HPV66 (11.2%), HPV33 (9.9%), HPV53 (9.2%), HPV81 (9.2%), HPV56 (7.9%) and HPV18 (6.6%). HPV prevalence was 86, 67, and 89% in women with invasive cervical carcinoma (ICC), high-grade squamous intraepithelial lesion (HSIL) and low-grade squamous intraepithelial lesion (LSIL), respectively. As for age distribution, 69% of all HPVs were found in women aged 20-29 years, and the HPV incidence rate deceased with increasing age. The proportion of single infections decreased as the severity of the cytological diagnosis increased, while the proportion of multiple infections increased. This study is the first of its type in Kuwait and one of few in the Middle East. The findings are consistent with the hypothesis that HPV infection is the primary cause of cervical neoplasia. They support HPV vaccine research to prevent cervical cancer and efforts to develop HPV DNA diagnostic tests.
Similar articles
Prevalence of human papillomavirus among women with normal cervical cytology in Kuwait.
Al-Awadhi R, Chehadeh W, Kapila K.J Med Virol. 2011 Mar;83(3):453-60. doi: 10.1002/jmv.21981.PMID: 21264866
Arbyn M, Benoy I, Simoens C, Bogers J, Beutels P, Depuydt C.Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):321-30. doi: 10.1158/1055-9965.EPI-08-0510.PMID: 19124515
Population-based study of human papillomavirus infection and cervical neoplasia in Athens, Greece.
Kroupis C, Thomopoulou G, Papathomas TG, Vourlidis N, Lazaris AC.Epidemiol Infect. 2007 Aug;135(6):943-50. doi: 10.1017/S095026880700876X. Epub 2007 Jun 7.PMID: 17553178 Free PMC article.
Are 20 human papillomavirus types causing cervical cancer?
Arbyn M, Tommasino M, Depuydt C, Dillner J.J Pathol. 2014 Dec;234(4):431-5. doi: 10.1002/path.4424.PMID: 25124771 Review.
Persistent human papillomavirus infection and cervical neoplasia.
Ferenczy A, Franco E.Lancet Oncol. 2002 Jan;3(1):11-6. doi: 10.1016/s1470-2045(01)00617-9.PMID: 11905599 Review.
Cited by
Alsanafi M, Salim NA, Sallam M.Hum Vaccin Immunother. 2023 Dec 31;19(1):2194772. doi: 10.1080/21645515.2023.2194772. Epub 2023 Apr 2.PMID: 37005342 Free PMC article.
Amin FAS, Un Naher Z, Ali PSS.J Cancer Res Clin Oncol. 2023 Mar 31. doi: 10.1007/s00432-023-04710-5. Online ahead of print.PMID: 37000261 Review.
Barriers to the HPV vaccination program in the Eastern Mediterranean region: a narrative review.
Hakimi S, Lami F, Allahqoli L, Alkatout I.J Turk Ger Gynecol Assoc. 2023 Mar 15;24(1):48-56. doi: 10.4274/jtgga.galenos.2022.2022-6-6. Epub 2022 Dec 30.PMID: 36583290 Free PMC article.
Fernandes Q, Allouch S, Gupta I, Elmakaty I, Elzawawi KE, Amarah A, Al-Thawadi H, Al-Farsi H, Vranic S, Al Moustafa AE.Pathogens. 2022 Nov 19;11(11):1380. doi: 10.3390/pathogens11111380.PMID: 36422631 Free PMC article. Review.
Chaw L, Lee SHF, Ja'afar NIH, Lim E, Sharbawi R.PLoS One. 2022 Mar 14;17(3):e0262213. doi: 10.1371/journal.pone.0262213. eCollection 2022.PMID: 35287163 Free PMC article.